Literature DB >> 15351290

Modeling of homogeneous cloned enzyme donor immunoassay.

Sang Il Jeon1, Xiaoyun Yang, Joseph D Andrade.   

Abstract

One of the most widely used analytical techniques for sensitive detection of biologically and clinically significant analytes is the immunoassay. In recent years direct immunoprobes allowing label-free detection of the interaction between the antibody and the target analyte have proved their capabilities as fast, simple, and nevertheless highly sensitive methods. Cloned enzyme donor immunoassay (CEDIA) homogeneous assay is based on the bacterial enzyme beta-galactosidase, which has been genetically engineered into two inactive fragments, enzyme donor and enzyme acceptor. Reassociation of the fragments in the assay forms active enzyme, which acts on substrate to generate a colored product. A comprehensive kinetic model of CEDIA is developed to aid in understanding this method and to facilitate development of a truly homogeneous version, potentially applicable to a dipstick-type multianalyte point of care analytical device (ChemChip). Although the standard assay involves a two-step process, we also chose to model a single-combined process, which would be simpler to apply in a ChemChip device. From the modeling simulation, we obtain the time courses of the amounts of product and active enzyme, from which the dynamic ranges can be obtained as 10(-6)-10(-7) and 10(-5)-10(-7)M analyte concentration for two-step and single-combined processes under the conditions of the assumed parameters, respectively. A simple one-step immunoassay has the merit of reducing time and cost and has an improved dynamic range.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351290     DOI: 10.1016/j.ab.2004.06.044

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  1 in total

1.  An ImmunoChip prototype for simultaneous detection of antiepileptic drugs using an enhanced one-step homogeneous immunoassay.

Authors:  Xiaoyun Yang; Jarmila Janatova; Joetta M Juenke; Gwendolyn A McMillin; Joseph D Andrade
Journal:  Anal Biochem       Date:  2007-03-24       Impact factor: 3.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.